Panax ginseng modulates cytokines in bone marrow toxicity and myelopoiesis: Ginsenoside RG1 partially supports myelopoiesis

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Raghavendran, Hanumantha Rao Balaji ^a   Sathyanath, Rekha ^a   Shin, JangWoo ^a   Kim, Hyeong Keug ^a   Han, Jong Min ^a   Cho, JungHyo ^a   Son, Chang Gue ^a  

^a Daejeon University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; GINSENG EXTRACT; GINSENOSIDE RG 1; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 13; GINSENOSIDE; INTERLEUKIN 3; INTERLEUKIN 6; STEM CELL FACTOR RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BONE MARROW CELL; BONE MARROW SUPPRESSION; BONE MARROW TOXICITY; COLONY FORMING UNIT GM; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG DOSE COMPARISON; ERYTHROPENIA; GENE; GENE EXPRESSION; GINSENG; HISTOPATHOLOGY; IL 1 GENE; IL 6 GENE; IN VITRO STUDY; LEUKOCYTE COUNT; LEUKOPENIA; LYMPHOCYTE COUNT; LYMPHOCYTOPENIA; MALE; MOUSE; MYELOPOIESIS; NEUTROPENIA; NEUTROPHIL COUNT; NONHUMAN; ONCOGENE C KIT; ORGAN WEIGHT; PLANT ROOT; SCF GENE; SPLEEN WEIGHT; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THYMUS WEIGHT; TNF ALPHA GENE; ANIMAL; BIOSYNTHESIS; BONE MARROW; C57BL MOUSE; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; HEMATOCRIT; METABOLISM; PANAX; PATHOLOGY; SPLEEN; THYMUS;

MUS; PANAX GINSENG;

ANIMALS; BONE MARROW; BONE MARROW CELLS; CELLS, CULTURED; FLUOROURACIL; GINSENOSIDES; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOCRIT; INTERLEUKIN-3; INTERLEUKIN-6; MALE; MICE; MICE, INBRED C57BL; MYELOPOIESIS; PANAX; PROTO-ONCOGENE PROTEINS C-KIT; SPLEEN; THYMUS GLAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84859824004     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033733     Document Type: Article

References (56)

1. Lund JE, (2000) Toxicologic effects on blood and bone marrow, in Schalm's Veterinary Hematology, 5th edition (B. F. Feldman, J. G. Zinkl, and N. C. Jain, eds.),. Lippincott, Williams and Wilkins, Philadelphia, PA pp. 44-50.
2. Ryan DH, (2001) Examination of the blood. In Williams Hematology, 6th edition. (E. Beutler, M. A. Lichtman, B. S. Coller, T. J. Kipps, and U. Seligsohn, eds.), McGraw-Hill, New York pp. 9-16.
3. Grem JL, (2000) 5-Fluorouracil: forty-plus and still ticking. A review of its preclinical and clinical development. Invest New Drugs 18: 299-313.
4. Tomiak A, Vincent M, Kocha W, Taylor M, Winquist E, et al. (2000) Standard dose (Mayo regimen) 5-fluorouracil and low does folinic acid: prohibitive toxicity? Am J Clin Oncol 23: 94-98.
5. Jodrell DI, Stewart M, Aird R, Knowles G, Bowman, A, et al. (2001) 5-Fluorouracil steady state pharmacokinetics and outcome in patients receiving protracted venous infusion for advanced colorectal cancer. Br J Can 84: 600-603.
6. Attele AS, Wu JA, Yuan CS, (1999) Ginseng pharmacology: Multiple constituents and multiple actions. Biochem Pharmacol 58: 1685-1693.
7. Yance DR Jr, Sagar SM, (2006) Targeting angiogenesis with integrative cancer therapies. Integ Can Therap 5: 9-29.
8. Kim HJ, Kim MH, Byon YY, Park JW, Jee Y, et al. (2007) Radioprotective effects of an acidic polysaccharide of Panax ginseng on bone marrow cells. J Vet Sci 8 (1): 39-44.
9. Zhang QH, Wu CF, Duan L, Yang JY, (2008) Protective effects of total saponins from stem and leaf of Panax ginseng against cyclophosphamide-induced genotoxicity and apoptosis in mouse bone marrow cells and peripheral lymphocyte cells. Food Chem Toxicol 46: 293-302.
10. Lu XZ, Wang JH, Wu X, Zhou L, Wang L, et al. (2008) Ginsenoside Rg1 promotes bone marrow stromal cells proliferation via the activation of the estrogen receptor-mediated signaling pathway. Acta Pharmacol Sin 29 (10): 1209-1214.
11. Leung KW, Pon YL, Wong RN, Wong AS, et al. (2006) Ginsenoside-Rg1 induces vascular endothelial growth factor expression through the glucocorticoid receptor-related phosphatidylinositol 3-kinase/Akt and betacatenin/T-cell factor-dependent pathway in human endothelial cells. J Biol Chem 36: 280-288.
12. Lee YJ, Chung E, Lee KY, Lee YH, Huh B, et al. (1997) Ginsenoside- Rg1, one of the major active molecules from Panax ginseng, is a functional ligand of glucocorticoid receptor. Mol Cell Endocrin 133: 135-40.
13. De Haan G, Donte B, Engel C, Loeffler M, Nijhof W, (1996) Prophylactic Pretreatment of Mice with Hematopoietic Growth Factors Induces Expansion of Primitive Cell Compartments and Results in Protection against 5-Fluorouracil-Induced Toxicity. Blood 87: 4581-4588.
14. Dinarello CA, Savage N, (1989) Interleukin-1 and its biologically related cytokines. Adv Immunol 44: 153-156.
15. Fackler MJ, Krause DS, Smith OM, Civin CI, et al. (1995) Full-length but not truncated CD34 inhibits hematopoietic cell differentiation of M1 cells. Blood 85: 3040-3047.
16. Almeida-Porada G, Ascensao IL, (1996) Isolation, characterization and biologic features of bone marrow endothelial cells. J Lab Clin Med 128: 399-407.
17. Nand S, Sosman J, Godwin JE, Fisher RI, (1994) A phase I/II study of sequential interleukin-3 and granulocyte-macrophage colony-stimulating factor in myelodysplastic syndromes. Blood 83: 357-360.
18. Jones AT, Ziltener HJ, (1993) Enhancement of the biologic effects of interleukin-3 in vivo by anti-interleukin-3 antibodies. Blood 82: 1133-1141.
19. Gilmore GL, DePasquale DK, Fischer BC, Shadduck RK, (1995) Enhancement of monocytopoiesis by granulocyte colony-stimulating factor. Exp Hematol 23: 1319-1323.
20. Lee DW Y, Lau ASY, (2011) Effects of Panax ginseng on Tumor Necrosis Factor-α-Mediated Inflammation: A Mini-Review. Molecules 16: 2802-2816.
21. Joo SS, Won TJ, Kim MS, Lee DI, (2004) Hematopoietic effect of ginsenoside Rg3 in ICR mouse primary cultures and its application to a biological response modifier. Fitoterapia 75: 337-341.
22. Koike K, Ogawa M, Ihle JN, Miyake T, Shimizu, et al. (1987) Recombinant murine granulocytemacrophage (GM) colony-stimulating factor supports formation of GM and multipotential blast cell colonies in culture: comparison with the effects of interleukin-3. J Cell Physiol 131: 458-464.
23. Leary AG, Yang YC, Clark SC, Gasson JC, et al. (1987) Ogawa M. Recombinant gibbon interleukin 3 supports formation of human multilineage colonies and blast cell colonies in culture: comparison with recombinant human granulocyte-macrophage colony-stimulating factor. Blood 70: 1343-1348.
24. Chen D, Wang SL, Wang YP, (2003) Experimental study on expression of GM-CSF from human endothelial cells and monocytes induced by total saponins of Panax ginseng. Zhongguo Zhong Xi Yi Jie He Za Zhi 23 (11): 845-7.
25. Gao RL, Chen XH, Lin XJ, Qian, XD, Xu WH, et al. (2007) Effects of notoginosides on proliferation and upregulation of GR nuclear transcription factor in hematopoietic cells. Acta Pharmacol Sin 28 (5): 703-11.
26. Chen XH, Gao RL, Zhen ZY, Qian XD, Xu WH, et al. (2006) Expression of apoptosis-related proteins in the human bone marrow hematopoietic cells treated by Panax Notoginosides. Zhongguo Shi Yan Xue Ye Xue Za Zhi 14 (2): 343-6.
27. Leonard JP, Quinto CM, Kozitza MK, Neben TY, Goldman SJ, (1994) Recombinant human interleukin- 11(rhIL-11) multilineage hematopoietic recovery in mice after a myelosuppressive regimen of sublethal irradiation and carboplatin. Blood 83: 1499.
28. Paquette RL, Zhou JY, Yang YC, Clark, SC, Koeffler HP, (1988) Recombinant gibbon interleukin-3 acts synergistically with recombinant human G-CSF and GM-CSF in vitro. Blood 71: 1596.
29. Winton EF, Srinivasiah J, Kim BK, Hillyer CD, Strobert EA, et al. (1994) Effect of recombinant human interleukin-6 and rhIL-3 on hematopoietic regeneration as demonstrated in a nonhuman primate chemotherapy model. Blood 84: 65.
30. Saif MW, (2005) Capecitabine versus continuous-infusion 5-fluorouracil for colorectal cancer: a retrospective efficacy and safety comparison. Clin Col Can 5: 89-100.
31. Davis TA, Robinson DH, Lee KP, Kessler SW, (1995) Porcine brain microvascular endothelial cells support the in vitro expansion of human primitive hematopoietic bone marrow progenitor cells with a high replanting potent: requirement for cell-to-cell interactions and colony-stimulating factor. Blood 85: 1751-1761.
32. Zeuner A, Signore M, Martinetti D, Bartucci M, Peschle C, et al. (2007) Chemotherapy-Induced Thrombocytopenia Derives from the Selective Death of Megakaryocyte Progenitors and Can Be Rescued by Stem Cell Factor. Cancer Res 67 (10) 2007.
33. Bartold PM, Haynes DR, (1991) Interleukin-6 production by human gingival fibroblasts. J Periodon Res 26: 339-345.
34. Ikebuchi K, Wong GG, Clark SC, Ihle JN, Hirai Y, et al. (1987) Interleukin-6 enhancement of interleukin-3-dependent proliferation of multipotential hemopoietic progenitors. Proc Natl Acad Sci 84: 9035.
35. Chang YS, Seo EK, Gyllenhaal C, Block KI, (2003) Panax ginseng: a role in cancer therapy? Integrat Cancer Therap 2: 13-33.
36. Yun TK, (2003) Experimental and epidemiological evidence on nonorgan specific cancer preventive effect of Korean ginseng and identification of active compounds. Mut Res 523: 63-74.
37. Rafii S, Shapiro F, Pettengell R, Ferris B, Nachman RL, et al. (1995) Human bone marrow microvascular endothelial cells support long-term proliferation and differentiation of myeloid and megakaryocytic progenitors. Blood 86: 3353-3363.
38. Smith K, (1998) Interleukin 2: Inception, impact, and implications. Science 240: 1169.
39. Metcalf D, (1989) The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells. Nature 339: 27.
40. Reya T, Contractor NV, Couzens MS, Wasik MA, Emerson SG, et al. (1998) Abnormal Myelocytic Cell Development in Interleukin-2 (IL-2)-Deficient Mice: Evidence for the Involvement of IL-2 in Myelopoiesis. Carding Blood 91 (8): 2935-2947.
41. Alenzi FQ, Al-Ghamdi SM, Tamimi WG, Al-Sebiany AM, El-Nashar IM, et al. (2005) Apoptosis Role of FAS/FAS Ligand System in the Regulation of Myelopoiesis. Yale J Biol Med 78: 25-36.
42. De Maria R, Zeuner A, Eramao A, Domenichelli C, Bonci D, et al. (1999) Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1. Nature 401: 489-93.
43. Dalmau SR, Freitas CS, Savino W, (1997) Radio- and chemoprotection of bone marrow cells by opposite cell cycle-acting cytokines. Leukemia Res 21: 93-99.
44. Smith JW, Urba WJ, (1992) The toxic and hematologic effects of interleukin-1 alpha administered in a phase I trial to patients with advanced malignancies. J Clin Oncol 10: 1141-52.
45. Cashman JD, Eaves CJ, Sarris AH, Eaves AC, (1998) MCP-1, not MIP-1a, is the endogenous chemokine that cooperates with TGF-b to inhibit the cycling of primitive normal but not leukemic (CML) progenitors in Long-term human marrow cultures. Blood 92: 2338.
46. Deonarain R, Verma A, Porter AC, Gewert DR, Platanias LC, et al. (2003) Critical roles for IFN-gamma in lymphoid development, myelopoiesis, and tumor development: Links to tumor necrosis factor alpha. Proc Nat Acad Sci 23: 13453-13458.
47. Li WM, Huang WQ, Huang YH, Jiang DZ, Wang QR, (2000) Positive and negative haematopoietic cytokines produced by bone marrow endothelial cells. Cytokine 12 (7): 1017-1023.
48. Batard P, Monier MN, Fortunel N, Ducos K, Sansilvestri-Morel P, et al. (2000) TGF-b1 maintains hematopoietic immaturity by a reversible negative control of cell cycle and induces CD34 antigen up-modulation. J Cell Sci 113: 383-390.
49. Vento S, Cainelli F, Temesgen Z, (2008) Lung infections after cancer chemotherapy. Lancet Oncol 9: 981-992.
50. Kang XM, Zhang QY, Tong DD, Zhao W, (2005) Experimental study on anti-angiogenesis in mice with Lewis lung carcinoma by lowdose of cyclophosphamide combined with ginsenoside Rg3. Zhongguo Zhong Xi Yi Jie He Za Zhi 25: 730-733.
51. Li HB, Liu WL, Zhang QY, Kang XM, Zhao WH, (2006) The efficacy analysis of low-dose cyclophosphamide combined with gimenoside Rg3 on advanced non-small cell lung cancer. J Pract Oncol 20: 18-20.
52. Chen MW, Yao Y, Shi ZH, (2005) Observation of curalive effect of combined 20(R)-ginsenoside Rg3 with chemotherapy on non-small - cell lung cancers. Mil Med J South China 19: 4-6.
53. Roodman GD, Bird A, Hutzler D, Montgomery W, (1987) Tumor necrosis factor-alpha and hematopoietic progenitors: effects of tumor necrosis factor on growth of erythroid progenitors CFU-E and BFU-E and hematopoietic cell lines K562, HL60, and HEL cells. Exp Hematol 15: 928-935.
54. Artym J, Zimecki M, (2007) The Effects of Lactoferrin on Myelopoiesis: Can we resolve the Controversy? Postepy Hig Med Dosw 61: 129-150.
55. Voog E, Bienvenu J, Warzocha K, Moullet I, Dumontet C, et al. (2000) Factors That Predict Chemotherapy-Induced Myelosuppression in Lymphoma Patients: Role of the Tumor Necrosis Factor Ligand-Receptor System. 2 J Clin Oncol 18 pp. 325-331.
56. Shi AW, Wang XB, Lu FX, Zhu MM, Kong XQ, (2009) Ginsenoside Rg1 promotes endothelial progenitor cell migration and proliferation. Acta Pharmacol Sin 30 (3): 299-306.